nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefalotin—SLC22A11—Methotrexate—lymphatic system cancer	0.304	0.304	CbGbCtD
Cefalotin—SLC22A7—Methotrexate—lymphatic system cancer	0.29	0.29	CbGbCtD
Cefalotin—SLC22A8—Methotrexate—lymphatic system cancer	0.177	0.177	CbGbCtD
Cefalotin—SLC22A6—Methotrexate—lymphatic system cancer	0.123	0.123	CbGbCtD
Cefalotin—ALB—Methotrexate—lymphatic system cancer	0.105	0.105	CbGbCtD
